The Blk pathway functions as a tumor suppressor in chronic myeloid leukemia stem cells

A therapeutic strategy for treating cancer is to target and eradicate cancer stem cells (CSCs) without harming their normal stem cell counterparts. The success of this approach relies on identification of molecular pathways that selectively regulate CSC function. Using BCR-ABL-induced chronic myeloi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Haojian, Peng, Cong, Hu, Yiguo, Li, Huawei, Sheng, Zhi, Chen, Yaoyu, Sullivan, Con, Cerny, Jan, Hutchinson, Lloyd, Higgins, Anne, Miron, Patricia, Zhang, Xueqing, Brehm, Michael, Li, Dongguang, Green, Michael R., Li, Shaoguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3408839/
https://www.ncbi.nlm.nih.gov/pubmed/22797726
http://dx.doi.org/10.1038/ng.2350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3408839/
https://www.ncbi.nlm.nih.gov/pubmed/22797726
http://dx.doi.org/10.1038/ng.2350

Ejemplares similares